HCN1: A Protein Involved in Neurotrophic Signaling and Therapeutic Potential

Target Name: HCN1

NCBI ID: G348980

HCN1

HCN1: A Protein Involved in Neurotrophic Signaling and Therapeutic Potential

HCN1, or high-concentration neurotrophic factor 1, is a protein that is expressed in various tissues throughout the central nervous system (CNS) and is involved in the process of neurotrophic signaling. Neurotrophic factors are a type of signaling molecule that are produced by neurons and can promote the survival and proliferation of neurons, as well as modulate the function of other cells in the nervous system.

HCN1 is a member of the neurotrophic factor family and is characterized by its ability to interact with specific receptors on the surface of neurons and other cells in the CNS. This interaction allows HCN1 to influence the survival and migration of these cells, as well as the production of other molecules that are involved in neurotrophic signaling.

One of the key functions of HCN1 is its ability to promote the growth and survival of neurons. This is achieved through the regulation of the cell cycle, as well as the production of factors that can influence the cell wall and the cytoskeleton.HCN1 has also been shown to promote the migration of neurons, both in the CNS and in other tissues, and to play a role in the regulation of neurotransmitter release and synaptic plasticity.

In addition to its role in promoting the survival and growth of neurons, HCN1 is also involved in the regulation of the adult nervous system (ANS) and the development of new neurons. This is achieved through the production of molecules that can influence the stem cell pool and the neural stem cell lineage.HCN1 has also been shown to play a role in the regulation of synaptic plasticity, as well as the modulation of neurotransmitter release and the regulation of ion channels in neurons.

The potential therapeutic benefits of HCN1 are vast and range from the treatment of neurodegenerative diseases to the enhancement of cognitive function and the regulation of stress. For example, HCN1 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. In addition, HCN1 has also been shown to be involved in the regulation of stress and anxiety, as well as the modulation of pain perception.

Given its involvement in a wide range of neurotrophic processes and its potential therapeutic benefits, HCN1 makes an attractive target for research and development. There is a growing body of research that is focused on the study of HCN1 and its role in the CNS, and further studies are likely to shed light on its complex biology and its potential as a drug target.

Protein Name: Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 1

Functions: Hyperpolarization-activated ion channel exhibiting weak selectivity for potassium over sodium ions (PubMed:28086084). Contributes to the native pacemaker currents in heart (If) and in neurons (Ih). May mediate responses to sour stimuli

The "HCN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HCN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets